THOMAS LYNCH
Profile
Related Companies
Titles
Company Name
Related People
DIRECTOR
BRIAN ADAMSKY, BRIAN K. ADAMSKY, JOSEPH BERARDINO, DONALD CALDWELL, MICHAEL GREENEBAUM, MICHAEL J. GREENEBAUM, STEWART GREENEBAUM, STEWART J. GREENEBAUM, WILLIAM HASELTINE, WILLIAM A HASELTINE, WILLIAM A. HASELTINE, REINHARD KURTH, REINHARD A. KURTH, TERRY LIERMAN, THOMAS A LYNCH, THOMAS A. LYNCH, JEFFREY MESHULAM, JEFFREY N. MESHULAM, SHAWN PATRICK O-BRIEN, THOMAS G. PAESE, THOMAS G. PEASE, TOM PEASE, ALEXANDER RICH, ALEXANDER G. RICH, M.G. SARNGADHARAN, M.G. SARNGAHARAN, JEFFREY STELLO, FREDERICK C. TECCE
DIRECTOR
SHAH ARCHIT, DAN ATON, MATTHEW BAIROS, GREGG G BRANDON, GREGG G. BRANDON, JEFF DILLEY, JENNIFER DUNHAM, RANDY ECCKER, BRIAN FITZGERALD, BRIAN H. FITZGERALD, TIM HEDKE, MARK HUDGINS, STEPHEN B. KAPLAN, JOHN KRASZNEKEWICZ, TOM LYNCH, CHRISTOPHER R MCCLEARY, CHRISTOPHER R. MCCLEARY, CHRISTOPHER NOE, JOHN OPPENHEIMER, GLENN T REIGER, GLENN T. REIGER, GLENN T. RIEGER, ARCHIT SHAH, ROBERT SIMMONS, GEORGE WEISS, GEORGE M WEISS, GEORGE M. WEISS, MARK K WRIGHT, JOHN WYANT, JOHN H WYANT, JOHN H. WYANT
DIRECTOR
EXECUTIVE OFFICER
EXECUTIVE OFFICER
EXECUTIVE OFFICER
DIRECTOR
DIRECTOR
EXECUTIVE OFFICER
EXECUTIVE OFFICER
EXECUTIVE OFFICER
EXECUTIVE OFFICER
DIRECTOR
DIRECTOR
DIRECTOR
EXECUTIVE OFFICER
EXECUTIVE OFFICER
EXECUTIVE OFFICER
DIRECTOR
EXECUTIVE OFFICER, DIRECTOR
Filings
Filing Date
Filing Type
Source URL
Industry Classifier
Detailed Industry
Revenue Range
Securities
First Sale Date
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2019-04-11
D
BIOTECHNOLOGY
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity
2019-02-08
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Debt
2017-02-23
D
PHARMACEUTICALS
PHARMACEUTICAL PREPARATIONS [2834]
DECLINE TO DISCLOSE
Equity, Debt
2016-03-21

